References
Meredith PA, Elliott HL, McSharry D, Kelman AW, Reid JL (1983) The pharmacokinetics of endralazine in essential hypertensives and in normotensive subjects. Br J Clin Pharmacol 16: 27–32
Reece PA, Cozamanis I, Zacest R (1983) Endralazine — a new hydralazine-like antihypertensive with high systemic bioavailability. Eur J Clin Pharmacol 25: 553–556
Reece PA, Cozamanis I, Zacest R (1982) Influence of acetylator phenotype on the pharmacokinetics of a new vasodilator anti-hypertensive endralazine. Eur J Clin Pharmacol 23: 523–527
Boxenbaum HG, Riegelman S, Elashoff RM (1974) Statistical estimations in pharmacokinetics. J Pharmacokinet Biopharm 2 [2]: 123–148
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Elliott, H.L., Meredith, P.A. & Reid, J.L. Pharmacokinetics of endralazine. Eur J Clin Pharmacol 26, 661 (1984). https://doi.org/10.1007/BF00543509
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00543509